nonlinear regression fitting model in prism 7.0 software (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
nonlinear regression fitting model in prism 7.0 software
Nonlinear Regression Fitting Model In Prism 7.0 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nonlinear+regression+fitting+model+in+prism+7%2E0+software/nonlinear+regression+fitting+model+in+prism+7+0+software/pm38007841-126-25-28
Average 90 stars, based on 1 article reviews
Nonlinear Regression Fitting Model In Prism 7.0 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nonlinear+regression+fitting+model+in+prism+7%2E0+software/nonlinear+regression+fitting+model+in+prism+7+0+software/pm38007841-126-25-28
Average 90 stars, based on 1 article reviews
nonlinear regression fitting model in prism 7.0 software - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: An in-line method for high-throughput screening of protein tyrosine phosphatase receptor type O inhibitors by capillary electrophoresis based on electrophoretically mediated microanalysis. Article Snippet: Protein tyrosine phosphatase receptor type O (PTPRO) plays an important role in inflammation-related pathways and has become an emerging drug target.. In this study, we developed an in-line capillary electrophoresis (CE) method for the investigation of the enzymatic activity of PTPRO, which was based on electrophoretically mediated microanalysis (EMMA).. After a thorough method validation of the optimized conditions, this protocol was successfully employed to determine the kinetics of PTPRO as well as the half-maximal inhibitory concentration (IC50) of two typical PTPRO inhibitors. |